FDA
approval
· 2022-05-03
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Dr.Reddys Laboratories Inc)
Summary
FDA granted approval of Dr. Reddy's supplemental application for buprenorphine/naloxone; this generic product is approved for the treatment of opioid use disord…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)